AR095939A1 - Vacuna contra garrapatas rhipicephalus - Google Patents
Vacuna contra garrapatas rhipicephalusInfo
- Publication number
- AR095939A1 AR095939A1 ARP140101415A ARP140101415A AR095939A1 AR 095939 A1 AR095939 A1 AR 095939A1 AR P140101415 A ARP140101415 A AR P140101415A AR P140101415 A ARP140101415 A AR P140101415A AR 095939 A1 AR095939 A1 AR 095939A1
- Authority
- AR
- Argentina
- Prior art keywords
- vaccine against
- tickets
- against rhipicephalus
- rhipicephalus
- against ticks
- Prior art date
Links
- 241001481703 Rhipicephalus <genus> Species 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 241000238876 Acari Species 0.000 abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 239000012634 fragment Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0003—Invertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F23/00—Mixing according to the phases to be mixed, e.g. dispersing or emulsifying
- B01F23/40—Mixing liquids with liquids; Emulsifying
- B01F23/41—Emulsifying
- B01F23/4105—Methods of emulsifying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
Abstract
La presente se refiere, en general, a los campos de la parasitología y la inmunología, y especialmente a una vacuna contra las garrapatas del género Rhipicephalus. En particular, se refiere a una composición que comprende una primera y una segunda proteína, en particular las proteínas Bm86 y Subolesina, incluyendo sus homólogos o fragmentos inmunógenos; al uso de dicha composición como una vacuna contra las garrapatas del género Rhipicephalus, y al uso de la primera y la segunda proteína aislada para la vacunación de un objetivo contra las garrapatas del género Rhipicephalus. Método, kit.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13161834 | 2013-03-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR095939A1 true AR095939A1 (es) | 2015-11-25 |
Family
ID=48044656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP140101415A AR095939A1 (es) | 2013-03-29 | 2014-03-28 | Vacuna contra garrapatas rhipicephalus |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9579369B2 (es) |
| EP (1) | EP2978443B1 (es) |
| JP (1) | JP6586077B2 (es) |
| CN (1) | CN105228647B (es) |
| AR (1) | AR095939A1 (es) |
| AU (1) | AU2014242942B2 (es) |
| BR (1) | BR112015024882B8 (es) |
| CA (1) | CA2907748C (es) |
| ES (1) | ES2643031T3 (es) |
| MX (1) | MX357431B (es) |
| RU (1) | RU2677347C2 (es) |
| WO (1) | WO2014154847A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112019016143A2 (pt) | 2017-02-06 | 2020-04-07 | Australian Meat & Live Stock | composições imunoestimulantes e usos das mesmas |
| AU2018407589A1 (en) * | 2018-02-06 | 2020-09-10 | Meat & Livestock Australia Limited | Polypeptide, compositions and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL84574A (en) | 1986-11-27 | 1994-10-07 | Biotech Australia Pty Ltd | Beef tick antigen, its parts, homologous vapitopios with similar immune activity, process for their preparation, polynucleotide encoding them, vaccines containing them, antibodies derived from |
| US6235283B1 (en) * | 1986-11-27 | 2001-05-22 | Biotechnology Australia Pty. Ltd. | DNA encoding a cell membrane glycoprotein of a tick gut |
| EP0382271B1 (en) | 1989-02-04 | 1994-12-21 | Akzo Nobel N.V. | Tocols as adjuvant in vaccine |
| US6017757A (en) * | 1997-02-20 | 2000-01-25 | Mississippi State University | Isolated viable nematode intestinal cells |
| WO2001080881A1 (en) * | 2000-04-25 | 2001-11-01 | Evolutec Limited | Vaccine comprising a tick cement protein |
| US20060040361A1 (en) * | 2002-04-29 | 2006-02-23 | The Board Of Regents For Oklahoma State University | Protective antigens and vaccines for the control of multi species tick infestations |
-
2014
- 2014-03-28 EP EP14713130.4A patent/EP2978443B1/en active Active
- 2014-03-28 AR ARP140101415A patent/AR095939A1/es active IP Right Grant
- 2014-03-28 BR BR112015024882A patent/BR112015024882B8/pt active IP Right Grant
- 2014-03-28 WO PCT/EP2014/056248 patent/WO2014154847A1/en active Application Filing
- 2014-03-28 RU RU2015146326A patent/RU2677347C2/ru active
- 2014-03-28 CN CN201480030122.3A patent/CN105228647B/zh active Active
- 2014-03-28 JP JP2016504686A patent/JP6586077B2/ja active Active
- 2014-03-28 US US14/780,115 patent/US9579369B2/en active Active
- 2014-03-28 AU AU2014242942A patent/AU2014242942B2/en active Active
- 2014-03-28 CA CA2907748A patent/CA2907748C/en active Active
- 2014-03-28 MX MX2015013808A patent/MX357431B/es active IP Right Grant
- 2014-03-28 ES ES14713130.4T patent/ES2643031T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2978443A1 (en) | 2016-02-03 |
| CN105228647B (zh) | 2019-04-30 |
| JP6586077B2 (ja) | 2019-10-02 |
| US9579369B2 (en) | 2017-02-28 |
| BR112015024882B1 (pt) | 2024-01-30 |
| ES2643031T3 (es) | 2017-11-21 |
| BR112015024882B8 (pt) | 2024-02-27 |
| EP2978443B1 (en) | 2017-09-13 |
| BR112015024882A2 (pt) | 2017-10-10 |
| US20160051649A1 (en) | 2016-02-25 |
| CN105228647A (zh) | 2016-01-06 |
| RU2677347C2 (ru) | 2019-01-16 |
| CA2907748C (en) | 2021-10-19 |
| AU2014242942B2 (en) | 2018-08-02 |
| CA2907748A1 (en) | 2014-10-02 |
| MX357431B (es) | 2018-07-09 |
| AU2014242942A1 (en) | 2015-09-24 |
| JP2016516739A (ja) | 2016-06-09 |
| WO2014154847A1 (en) | 2014-10-02 |
| MX2015013808A (es) | 2016-02-16 |
| RU2015146326A (ru) | 2017-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2018000320A1 (es) | Coadyuvantes basados en aceite (divisional de solicitud 201600650) | |
| BR112018012707A2 (pt) | inibidores da interação de menin-mll | |
| CL2017003151A1 (es) | Formulaciones para vacunas contra la neoplasia y métodos para preparar las mismas | |
| CL2017002422A1 (es) | Derivados de maitansinoide, conjugados de los mismos, y métodos de uso. | |
| BR112017018368A2 (pt) | composições contendo rna para o tratamento de doenças tumorais | |
| PE20150646A1 (es) | Metodos de tratamiento de una tauopatia | |
| BR112017012344A2 (pt) | anticorpos anti-c10orf54 e usos dos mesmos | |
| SV2017005486A (es) | Anticuerpos a tau y usos de los mismos | |
| GT201700131A (es) | Composiciones y métodos para anticuerpos dirigidos a bmp6 | |
| CR20170425A (es) | Nuevas proteínas específicas para pioverdina y pioquelina | |
| CO6331297A2 (es) | Composiciones adyuvantes novedosas | |
| BR112015030356A2 (pt) | métodos de tratamento de uma taupatia | |
| BR112019012796A2 (pt) | proteínas de ligação ao antígeno antineuropilina e métodos de uso das mesmas | |
| CU24405B1 (es) | Proteínas de variantes de secuencias de aminoácidos de cry1da1 activas para lepidópteros | |
| CL2015001111A1 (es) | Composición coadyuvante que comprende un hidrato de carbono unido al quitosano formando una base de schiff; formulación de vacuna que la comprende; método de elaboración; y uso de la vacuna. | |
| BR112017003578A2 (pt) | kit para radiomarcação com 68ga compreendendo um inibidor de metal | |
| AR104604A1 (es) | ANTICUERPOS ANTI-FcRn | |
| CL2019000019A1 (es) | Anticuerpos con baja inmunogenicidad y uso de los mismos | |
| BR112017020178A2 (pt) | vacina estreptocócica | |
| BR112017005524A2 (pt) | segmentos de rna viral como agentes imunomoduladores e componentes de vacina | |
| CL2015002271A1 (es) | Uso de protioconazol para inducir respuestas de defensa de anfitrión | |
| CL2015001562A1 (es) | Método para obtener una vacuna de mycoplasma. | |
| CO2019006424A2 (es) | Proteínas de unión a antígenos anti-gitr y métodos de uso de las mismas | |
| ECSP17015154A (es) | Métodos para mejorar el rendimiento miocárdico en pacientes con cirugía de fontan que utilizan composiciones de udenafilo | |
| UY36617A (es) | Proteínas de fusión inmunogénicas para el tratamiento del cáncer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |